Home/Pipeline/Early Detection Test for Rheumatoid Arthritis

Early Detection Test for Rheumatoid Arthritis

Rheumatoid Arthritis

DevelopmentActive

Key Facts

Indication

Rheumatoid Arthritis

Phase

Development

Status

Active

Company

Age Labs

About Age Labs

Age Labs is a Norwegian life science company that develops diagnostic tests for early detection of age-related diseases using advanced machine learning on epigenetic datasets. Their pipeline includes a groundbreaking early detection test for rheumatoid arthritis, a biological age predictor, and COVID-19 severity prediction tests, alongside custom biomarker development services for pharmaceutical and nutraceutical industries.

View full company profile

Therapeutic Areas

Rheumatology Aging Infectious Diseases

Other Rheumatoid Arthritis Drugs

Drug	Company	Phase	Status
CORTONE (cortisone)	Merck	Commercial	Active
Kevzara (sarilumab)	Regeneron Pharmaceuticals	Approved	Commercial
Actemra (tocilizumab)	Chugai Pharmaceutical	Approved	Commercial
Tocilizumab	Biocon	Filed	Regulatory Review
Humira	Abbott India	Approved	Commercial
KPL-404	Kiniksa Pharmaceuticals	Phase 2	In Development
Tibulizumab (ZB-106)	Zura Bio	Phase 1b	Completed
Zunsemetinib (ATI-450)	Aclaris Therapeutics	Phase 2b	Active
Natrunix Program	XBiotech	Not Specified	Active
LEAPS Technology	CEL-SCI	Pre-clinical	Early Development
Piclidenoson (CF101)	Can Fite Biopharma	Phase 3	Active/Completed
Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure)	LFB	Pre-clinical	Development (Partnership)